These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 33348896)
21. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing. Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642 [TBL] [Abstract][Full Text] [Related]
22. Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells. Blijlevens M; Komor MA; Sciarrillo R; Smit EF; Fijneman RJA; van Beusechem VW Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545483 [TBL] [Abstract][Full Text] [Related]
23. Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia. Wang L; Brooks AN; Fan J; Wan Y; Gambe R; Li S; Hergert S; Yin S; Freeman SS; Levin JZ; Fan L; Seiler M; Buonamici S; Smith PG; Chau KF; Cibulskis CL; Zhang W; Rassenti LZ; Ghia EM; Kipps TJ; Fernandes S; Bloch DB; Kotliar D; Landau DA; Shukla SA; Aster JC; Reed R; DeLuca DS; Brown JR; Neuberg D; Getz G; Livak KJ; Meyerson MM; Kharchenko PV; Wu CJ Cancer Cell; 2016 Nov; 30(5):750-763. PubMed ID: 27818134 [TBL] [Abstract][Full Text] [Related]
24. Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B. Kashyap MK; Kumar D; Villa R; La Clair JJ; Benner C; Sasik R; Jones H; Ghia EM; Rassenti LZ; Kipps TJ; Burkart MD; Castro JE Haematologica; 2015 Jul; 100(7):945-54. PubMed ID: 25862704 [TBL] [Abstract][Full Text] [Related]
25. Splicing factor SF3B1 promotes endometrial cancer progression via regulating KSR2 RNA maturation. Popli P; Richters MM; Chadchan SB; Kim TH; Tycksen E; Griffith O; Thaker PH; Griffith M; Kommagani R Cell Death Dis; 2020 Oct; 11(10):842. PubMed ID: 33040078 [TBL] [Abstract][Full Text] [Related]
31. Modulation of SF3B1 in the pre-mRNA spliceosome induces a RIG-I-dependent type I IFN response. Chang AY; Zhou YJ; Iyengar S; Pobiarzyn PW; Tishchenko P; Shah KM; Wheeler H; Wang YM; Loria PM; Loganzo F; Woo SR J Biol Chem; 2021 Nov; 297(5):101277. PubMed ID: 34619148 [TBL] [Abstract][Full Text] [Related]
32. Functional analysis of Hsh155/SF3b1 interactions with the U2 snRNA/branch site duplex. Carrocci TJ; Paulson JC; Hoskins AA RNA; 2018 Aug; 24(8):1028-1040. PubMed ID: 29752352 [TBL] [Abstract][Full Text] [Related]
33. Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42. Zhao B; Li Z; Qian R; Liu G; Fan M; Liang Z; Hu X; Wan Y J Biochem; 2022 Jul; 172(2):117-126. PubMed ID: 35652295 [TBL] [Abstract][Full Text] [Related]
34. An important class of intron retention events in human erythroblasts is regulated by cryptic exons proposed to function as splicing decoys. Parra M; Booth BW; Weiszmann R; Yee B; Yeo GW; Brown JB; Celniker SE; Conboy JG RNA; 2018 Sep; 24(9):1255-1265. PubMed ID: 29959282 [TBL] [Abstract][Full Text] [Related]
35. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency. Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L mBio; 2018 Nov; 9(6):. PubMed ID: 30401776 [TBL] [Abstract][Full Text] [Related]
36. Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts. Conte S; Katayama S; Vesterlund L; Karimi M; Dimitriou M; Jansson M; Mortera-Blanco T; Unneberg P; Papaemmanuil E; Sander B; Skoog T; Campbell P; Walfridsson J; Kere J; Hellström-Lindberg E Br J Haematol; 2015 Nov; 171(4):478-90. PubMed ID: 26255870 [TBL] [Abstract][Full Text] [Related]
37. SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemia. Han C; Khodadadi-Jamayran A; Lorch AH; Jin Q; Serafin V; Zhu P; Politanska Y; Sun L; Gutierrez-Diaz BT; Pryzhkova MV; Abdala-Valencia H; Bartom ET; Buldini B; Basso G; Velu SE; Sarma K; Mattamana BB; Cho BK; Obeng RC; Goo YA; Jordan PW; Tsirigos A; Zhou Y; Ntziachristos P Sci Adv; 2022 Jan; 8(3):eabj8357. PubMed ID: 35061527 [TBL] [Abstract][Full Text] [Related]
38. Impact of cancer-associated mutations in Hsh155/SF3b1 HEAT repeats 9-12 on pre-mRNA splicing in Saccharomyces cerevisiae. Kaur H; Groubert B; Paulson JC; McMillan S; Hoskins AA PLoS One; 2020; 15(4):e0229315. PubMed ID: 32320410 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA biogenesis is broadly disrupted by inhibition of the splicing factor SF3B1. Downie Ruiz Velasco A; Parsons AL; Heatley MC; Martin ARG; Smart AD; Shah N; Jopling CL Nucleic Acids Res; 2024 Aug; 52(15):9210-9229. PubMed ID: 38884273 [TBL] [Abstract][Full Text] [Related]
40. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage. Alsafadi S; Houy A; Battistella A; Popova T; Wassef M; Henry E; Tirode F; Constantinou A; Piperno-Neumann S; Roman-Roman S; Dutertre M; Stern MH Nat Commun; 2016 Feb; 7():10615. PubMed ID: 26842708 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]